4-aminopyridine has been researched along with pemoline in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boërio, D; Créange, A; Hogrel, JY; Lefaucheur, JP | 1 |
| Deng, XY; Wang, L; Yang, TT; Yu, G | 1 |
2 review(s) available for 4-aminopyridine and pemoline
| Article | Year |
|---|---|
[Pathophysiology and treatment of fatigue in multiple sclerosis].
Topics: 4-Aminopyridine; Acute Disease; Amantadine; Amifampridine; Asthenia; Benzhydryl Compounds; Central Nervous System; Chronic Disease; Fatigue; Humans; Mental Fatigue; Modafinil; Multiple Sclerosis; Pemoline; Peripheral Nervous System; Physical Exertion; Severity of Illness Index; Surveys and Questionnaires | 2006 |
Pharmacological treatments for fatigue in patients with multiple sclerosis: A systematic review and meta-analysis.
Topics: 4-Aminopyridine; Amantadine; Central Nervous System Stimulants; Dopamine Agents; Drug Therapy; Fatigue; Humans; Multiple Sclerosis; Pemoline | 2017 |